BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,119,363 | +53.3% | 1,748,933 | 0.0% | 1.54% | +76.6% |
| Q2 2023 | $30,081,647 | -4.9% | 1,748,933 | -8.3% | 0.87% | -6.7% |
| Q1 2023 | $31,618,607 | +144.5% | 1,907,033 | +12.4% | 0.93% | +157.3% |
| Q4 2022 | $12,931,391 | -23.3% | 1,697,033 | 0.0% | 0.36% | -25.9% |
| Q3 2022 | $16,869,000 | +9.5% | 1,697,033 | 0.0% | 0.49% | +1.4% |
| Q2 2022 | $15,409,000 | -60.5% | 1,697,033 | -55.8% | 0.48% | -38.2% |
| Q1 2022 | $38,969,000 | -83.6% | 3,839,380 | -73.1% | 0.78% | -57.4% |
| Q4 2021 | $237,814,000 | -34.6% | 14,257,510 | +83.8% | 1.83% | -65.3% |
| Q3 2021 | $363,567,000 | -61.6% | 7,756,928 | -50.0% | 5.28% | -14.0% |
| Q2 2021 | $945,724,000 | +97.9% | 15,513,856 | +100.0% | 6.14% | +1.6% |
| Q1 2021 | $477,827,000 | +0.2% | 7,756,928 | +15.7% | 6.04% | +18.1% |
| Q4 2020 | $476,883,000 | +89.5% | 6,706,268 | 0.0% | 5.12% | +39.3% |
| Q3 2020 | $251,619,000 | +15.1% | 6,706,268 | 0.0% | 3.67% | +3.6% |
| Q2 2020 | $218,691,000 | +12.4% | 6,706,268 | 0.0% | 3.54% | -30.0% |
| Q1 2020 | $194,481,000 | +36.7% | 6,706,268 | 0.0% | 5.06% | +79.2% |
| Q4 2019 | $142,273,000 | -1.2% | 6,706,268 | 0.0% | 2.83% | -27.1% |
| Q3 2019 | $143,983,000 | -20.4% | 6,706,268 | 0.0% | 3.88% | -6.5% |
| Q2 2019 | $180,868,000 | – | 6,706,268 | – | 4.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |